Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Glucose Control”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02173457
What this trial is testing

Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Chipscreen Biosciences, Ltd. 740
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07139405
What this trial is testing

TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin Therapy

Who this might be right for
Type 2 Diabetes (T2DM)
Myopharm Limited 48
Not applicableStudy completedNCT03793023
What this trial is testing

Observational Study to Evaluate the Efficacy and Safety of Teneligliptin

Who this might be right for
Type 2 Diabetes Mellitus
Handok Inc. 2,983
Large-scale testing (Phase 3)Study completedNCT02567994
What this trial is testing

Tenelia Triple Combination Study

Who this might be right for
Type 2 Diabetes Mellitus
Handok Inc. 201
Large-scale testing (Phase 3)Study completedNCT00885352
What this trial is testing

Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 313
Large-scale testing (Phase 3)Study completedNCT01296412
What this trial is testing

Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 653
Large-scale testing (Phase 3)Study completedNCT02354222
What this trial is testing

Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 154
Large-scale testing (Phase 3)Study completedNCT06589765
What this trial is testing

HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin

Who this might be right for
Type 2 Diabetes
Shandong Suncadia Medicine Co., Ltd. 810
Large-scale testing (Phase 3)Study completedNCT06010004
What this trial is testing

A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 401
Large-scale testing (Phase 3)UnknownNCT03159052
What this trial is testing

Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Jiangsu HengRui Medicine Co., Ltd. 450
Large-scale testing (Phase 3)Study completedNCT01106690
What this trial is testing

The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 344
Large-scale testing (Phase 3)Study completedNCT00798161
What this trial is testing

Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 857
Post-approval studies (Phase 4)Study completedNCT02471404
What this trial is testing

Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea

Who this might be right for
Type 2 Diabetes MellitusInadequate Glycaemic Control
AstraZeneca 939
Large-scale testing (Phase 3)Study completedNCT00106704
What this trial is testing

Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 441
Post-approval studies (Phase 4)Study completedNCT02906709
What this trial is testing

Omarigliptin Add-on to Insulin in Japanese Participants With Type 2 Diabetes Mellitus (T2DM, MK-3102-039)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 184
Large-scale testing (Phase 3)Study completedNCT00350779
What this trial is testing

Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 262
Early research (Phase 1)Study completedNCT02500979
What this trial is testing

Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
AstraZeneca 34
Post-approval studies (Phase 4)Ended earlyNCT00832624
What this trial is testing

The Effect of Sitagliptin in Type 2 Diabetes Mellitus With Inadequate Glycemic Control (MK0431-118)

Who this might be right for
Diabetes Mellitus Non-insulin-dependent
Merck Sharp & Dohme LLC 10
Large-scale testing (Phase 3)Study completedNCT03842267
What this trial is testing

Evaluate the Efficacy and Safety of Gemigliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin (SOLUTION Study)

Who this might be right for
Diabetes Mellitus, Type 2
LG Chem 315
Large-scale testing (Phase 3)Study completedNCT01606007
What this trial is testing

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,282
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation